Viscosupplementation - South America Analysis and Market Forecasts - New Market Report

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability across the globe. Intra-articular viscosupplementation with hyaluronic acid (HA) has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade. Going forward, palliative pain treatments are likely to continue to fare well as healthcare reform kicks in and lag times for knee replacement become the norm.

The increasing prevalence of OA and the lower cost of prescribing viscosupplementation compared with knee replacement surgery have prompted the medical community to take a closer look at this therapy. However, there is a growing concern among physicians that the updated American Academy of Orthopaedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will result in increased insurance denials for viscosupplementation. Moving forward, industry consolidation and intense competition in the viscosupplementation arena will cause increasing numbers of companies to augment their research efforts to differentiate their products from the lower-end competitors. The motivation to incorporate the favorable properties of different agents into a more effective viscosupplementation product has led to the manipulation and development of next-generation HA formulations consisting of not only HAs, but also pharmaceuticals, such as corticosteroids.

Full Report Details at
- http://www.fastmr.com/prod/1058669_viscosupplementation_south.aspx?afid=301

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

* Future growth in the viscosupplementation market lies in the one-injection segment. What are the current adoption trends in Brazil? How will one-injection segment drive the market revenue growth in the upcoming years?
* Reimbursement is the single greatest barrier to the market growth for viscosupplementation procedures. How does the current payer mix look like in Brazil?
* In recent years, there has been an expansion in the use of intra-articular HA viscosupplementation for treating OA at hips, shoulders, and other small joints. What are the current adoption trends in Brazil?
* Because the most prevalent treatment regimen varies from region to region, the competitive landscape in the viscosupplementation space can be quite different across the geographies covered in this report. Who are the leading players in the viscosupplementation market in Brazil?

Reasons to Get this Report

* "What Do Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Companies Mentioned in this Report: Anika Therapeutics, Chugai Pharmaceutical, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Meda AB, Sanofi, Seikagaku Corporation, Bioventus, DePuy Synthes, Zimmer-Biomet

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
- MediPoint: Viscosupplementation - Global Analysis and Market Forecasts
- MediPoint: Prosthetic Heart Valves - South America Analysis and Market Forecasts
- MediPoint: Nuclear Imaging - South America Analysis and Market Forecasts
- Non-Vascular Stents - SA Analysis and Market Forecasts